Article | 2026 ASRS Meeting
What Retina Specialists Have Learned From TRUCKEE
Carl J. Danzig, MD, reviews 4.5 years of real-world findings showing sustained anatomic improvements, longer treatment intervals, and a favorable safety profile with faricimab in neovascular AMD.







